IOPtima Launches iLid™ CO 2 Laser-Assisted Blepharoplasty Kit
Patients experience shorter recovery and minimal bruising, swelling and pain compared to manual procedures
TEL AVIV – July 11, 2017 – IOPtima Ltd., a developer of laser-assisted surgical ophthalmic devices and accessories, today announced the launch of the iLid™ CO 2 laser kit to enable oculoplastic surgeons to perform safe, effective CO 2 laser-assisted blepharoplasty, a cosmetic procedure that corrects defects, deformities and disfigurations of the eyelids. Blepharoplasty can be performed manually with a surgical scalpel; the iLid CO 2 laser kit facilitates use of a CO 2 laser beam instead.
With the excision and removal and/or repositioning of excess tissues, as well as reinforcement muscle and tendon tissues, the blepharoplasty procedure is used to treat:
- Loose or sagging skin that creates folds or disturbs the natural contour of the upper eyelids, sometimes impairing vision
- Excess fatty deposits that appear as puffiness in the eyelids
- Bags under the eyes
- Drooping lower eyelids that reveal white below the iris
- Excess skin and fine wrinkles of the lower eyelids
Using the iLid CO 2 laser kit instead of a manual surgical scalpel, surgeons employ a CO 2 laser beam with adjustable levels of penetration to incise the upper and lower eyelids and remove excess fat. The CO 2 laser beam also carefully vaporizes (peels) the top layer of the skin, restoring its surface and finely smoothing the lid. Advantages iLid CO 2 laser-assisted blepharoplasty surgery over older scalpel techniques include 1 :
- No skin incision in the lower eyelid, eliminating any potential dragging down of the lower eyelid
- Minimal bruising, swelling, pain and discomfort
- Shorter recovery period
- Less intraoperative bleeding as the laser seals blood vessels as it cuts, eliminating small subcutaneous and intramuscular hematomas
- Dramatically reduced procedure time
- Better cosmetic results with no visible scars
“I have been performing CO 2 laser-assisted blepharoplasty for over a decade now, and I cannot imagine my practice without it. This safe procedure allows me to eliminate intraoperative bruising and swelling and provide a bloodless environment during the incision, which in turn contributes to my ability to make precise decisions in real time, thus avoiding the complications I used to experience with manual procedures,” said Dr. Paolo Bonan, Laser Surgery Researcher and Head of the Laser Cutaneous, Cosmetic and Plastic Surgery Unit, Villa Donatello, Florence, Italy. “CO 2 laser-assisted blepharoplasty reduces the operation time, so we are able to treat more patients and run a more efficient operating room. And when it comes to the most important goals, our patients' satisfaction and quality of life, we see shorter recovery time with no visible scars and better cosmetic results compared to the manual procedure.”
The iLid CO 2 laser-assisted blepharoplasty kit is based on IOPtima’s IOPtiMate™ system for performing CLASS™ (CO 2 laser-assisted sclerectomy surgery) for treatment of glaucoma. According to IOPtima CEO Ronen Castro, “Customer feedback and IOPtima’s ongoing commitment to delivering the latest product applications have driven the development of the iLid kit. Dual use of this technology by both glaucoma specialists and oculoplastic surgeons allows clinics to have two applications in one device and one convenient installation, broadening the scope of the clinic’s activities.”
1 Leclère, F. M., Alcolea, J., Mordon, S., Servell, P., Kolb, F., Unglaub, F., & Trelles, M. A. (2013). Long-term outcomes of laser assisted blepharoplasty for ptosis: About 104 procedures in 52 patients. Journal of Cosmetic and Laser Therapy, 15(4), 193-199.
About IOPtima’s CLASS™ with the IOPtiMate™ System
With a mission to address the unmet needs and common safety problems in glaucoma surgery, IOPtima has developed a procedure called CLASS (CO 2 laser-assisted sclerectomy surgery). This elegant, self-regulated procedure is performed using the IOPtiMate™ system. Designed to achieve optimal functional results from surgery, the simple, safe, reproducible procedure results in minimal side effects and reduced recovery time.
About IOPtima Ltd.
Established in 2005, IOPtima Ltd., a Bio-Light company (BOLT:TASE), is a developer of laser-assisted surgical ophthalmic devices and additional innovative products for ophthalmic surgeries. The company’s flagship product, the IOPtiMate™, is a surgical system for the treatment of glaucoma. It utilizes CO 2 laser technology to significantly reduce intraocular pressure (IOP) by restoring the natural fluid percolation without penetrating the eye. For more information about IOPtima, please visit the company’s website: www.IOPtima.co.il
Source: IOPtima Ltd.